ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,237.72
-0.42%
Dow Jones
39,150.33
0.04%
Gold vs US Dollar
2,320.79
0.00%
Brent Oil
84.39
0.00%
Bitcoin
64,063.76
-0.28%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Purple Biotech Ltd (PPBT) Share Price

PPBT Purple Biotech Ltd

0.5176
0.0304 (6.24%)
22 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Purple Biotech Ltd NASDAQ:PPBT NASDAQ Depository Receipt  ADS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.0304 6.24 0.5176 0.489 1.47 0.51 0.47 0.5092 124,798 04:00:02   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -19.88M - N/A 
 Type  Size  Price  Time  Units 
 20 100 0.5176 21:35:46 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore PPBT News
20/06/202414:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
04/06/202421:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
03/06/202411:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
01/06/202413:00GLOBEPurple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer
21/05/202412:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
21/05/202412:30GLOBEPurple Biotech Reports First Quarter 2024 Financial Results
25/04/202412:00GLOBEPurple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
Period
Draw mode
Data Downloads for PPBT

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Purple Biotech Ltd Articles